Levofloxacin versus placebo for the prevention of tuberculosis disease in child contacts of multidrug-resistant tuberculosis: study protocol for a phase III cluster randomised controlled trial (TB-CHAMP)

BACKGROUND: Multidrug-resistant (MDR) tuberculosis (TB) presents a challenge for global TB control. Treating individuals with MDR-TB infection to prevent progression to disease could be an effective public health strategy. Young children are at high risk of developing TB disease following infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Seddon, James A., Garcia-Prats, Anthony J., Purchase, Susan E., Osman, Muhammad, Demers, Anne-Marie, Hoddinott, Graeme, Crook, Angela M., Owen-Powell, Ellen, Thomason, Margaret J., Turkova, Anna, Gibb, Diana M., Fairlie, Lee, Martinson, Neil, Schaaf, H. Simon, Hesseling, Anneke C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302301/
https://www.ncbi.nlm.nih.gov/pubmed/30572905
http://dx.doi.org/10.1186/s13063-018-3070-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302301/
https://www.ncbi.nlm.nih.gov/pubmed/30572905
http://dx.doi.org/10.1186/s13063-018-3070-0

Ejemplares similares